Skip to content
DataLookout
Menu

TOPGUN-PilotNCT06718439

Hemoglobin Levels for Blood Transfusions During and After Surgery

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 13 words
    • Enrollment closed, study ongoing
    • Primary completion date changed from estimate of Apr 15, 2026 to Sep 16, 2026
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jan 15, 2026 to Apr 15, 2026
    • Site details revised
    v3
  3. Notable Start date: Jan 15, 2025 to Apr 16, 2025v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Recruitment rate
Timeframe: 12 months post site initiation
Intervention adherence
Timeframe: From enrollment up to 6 hours in the Post-Anesthetic Care Unit
Participant retention
Timeframe: From randomization to 30 days post surgery.

Arms and interventions

Restrictive transfusion strategyExperimental

The restrictive transfusion strategy will consist of administering red blood cell transfusion when the participant's hemoglobin level is measured below 70 g/L or to maintain a hemoglobin target range of 70-80 g/L.

Liberal transfusion strategyExperimental

The liberal transfusion strategy will consist of administering red blood cell transfusion when the participant's hemoglobin level is measured below 90 g/L or to maintain a hemoglobin target range of 90-100 g/L.

Procedures: Restrictive Transfusion, Liberal transfusion

Sites

1 site in 1 country

  • The Ottawa HospitalOttawa, Ontario, Canada